The Hartford Healthcare Fund Class C (HGHCX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
25.29
+0.15 (0.60%)
At close: Feb 13, 2026
Fund Assets834.13M
Expense Ratio2.07%
Min. Investment$2,000
Turnover40.00%
Dividend (ttm)1.90
Dividend Yield7.53%
Dividend Growth-26.10%
Payout Frequencyn/a
Ex-Dividend DateDec 11, 2025
Previous Close25.14
YTD Return-0.71%
1-Year Return9.68%
5-Year Return5.22%
52-Week Low19.86
52-Week High26.24
Beta (5Y)n/a
Holdings82
Inception DateMay 1, 2000

About HGHCX

Hartford Healthcare Fund Class C is a mutual fund focused on the global healthcare sector. Its primary objective is long-term capital appreciation, achieved by investing in a diversified portfolio of companies involved in the global healthcare industry. The fund seeks to capitalize on broad trends such as demographic shifts, globalization, and innovation within healthcare. It maintains flexibility to invest across various subsectors, including pharmaceuticals, biotechnology, medical products, medical services, and healthcare delivery. The portfolio is constructed through in-depth research, aiming to include the best investment ideas identified by a team of managers and analysts. Currently, nearly half of its assets are concentrated in its top ten holdings, which feature leading healthcare companies. The fund is sub-advised by Wellington Management, known for its collaborative and research-driven approach across asset classes. Hartford Healthcare Fund Class C plays a significant role for investors seeking access to growth opportunities within the healthcare sector, blending large-cap exposure with selective innovation-driven firms. It serves as a sector-specific investment option for diversified portfolios, targeting those interested in the long-term prospects and resilience of healthcare markets.

Fund Family Hartford Mutual Funds
Category Health
Performance Rating Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol HGHCX
Share Class Class C
Index S&P Composite 1500 Health Care TR

Performance

HGHCX had a total return of 9.68% in the past year, including dividends. Since the fund's inception, the average annual return has been 14.93%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

SymbolShare ClassExpense Ratio
HGHFXClass F0.92%
HGHVXClass R60.92%
HGHIXClass I1.02%
HGHYXClass Y1.03%

Top 10 Holdings

48.82% of assets
NameSymbolWeight
Eli Lilly and CompanyLLY13.63%
Merck & Co., Inc.MRK5.46%
UnitedHealth Group IncorporatedUNH5.32%
Johnson & JohnsonJNJ4.74%
AbbVie Inc.ABBV4.18%
Intuitive Surgical, Inc.ISRG3.93%
Danaher CorporationDHR3.09%
Edwards Lifesciences CorporationEW2.95%
Medtronic plcMDT2.76%
Vertex Pharmaceuticals IncorporatedVRTX2.76%
View More Holdings

Dividend History

Ex-DividendAmountPay Date
Dec 11, 2025$1.40315Dec 12, 2025
Dec 11, 2024$1.89862Dec 12, 2024
Dec 12, 2022$0.36137Dec 13, 2022
Dec 10, 2021$4.37361Dec 13, 2021
Dec 10, 2020$5.16605Dec 11, 2020
Dec 10, 2019$2.36232Dec 11, 2019
Full Dividend History